Bridgefront Capital, LLC Takeda Pharmaceutical CO LTD Transaction History
Bridgefront Capital, LLC
- $249 Million
- Q3 2024
A detailed history of Bridgefront Capital, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Bridgefront Capital, LLC holds 46,257 shares of TAK stock, worth $615,218. This represents 0.26% of its overall portfolio holdings.
Number of Shares
46,257
Previous 21,373
116.43%
Holding current value
$615,218
Previous $276,000
138.04%
% of portfolio
0.26%
Previous 0.12%
Shares
9 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
73.8MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$175 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$71.2 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$67.8 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$61.7 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$60.7 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...